Neocryptotanshinone protects against myocardial ischemia-reperfusion injury by promoting autolysosome degradation of protein aggregates via the ERK1/2-Nrf2-LAMP2 pathway

被引:13
|
作者
Yang, Ye [1 ,2 ]
Shao, Mingyan [2 ,3 ]
Yao, Junkai [1 ,2 ]
Yang, Shuangjie [3 ]
Cheng, Wenkun [2 ,3 ]
Ma, Lin [2 ,4 ]
Li, Weili [2 ,4 ]
Cao, Jing [2 ,3 ]
Zhang, Yawen [2 ,3 ]
Hu, Yueyao [2 ,3 ]
Li, Chun [2 ,5 ]
Wang, Yong [2 ,3 ]
Wang, Wei [2 ,6 ]
机构
[1] Beijing Univ Chinese Med, Dongzhimen Hosp, Beijing 100700, Peoples R China
[2] Beijing Univ Chinese Med, Key Lab TCM Syndrome & Formula, Minist Educ, Beijing 100700, Peoples R China
[3] Beijing Univ Chinese Med, Sch Chinese Med, Beijing 100029, Peoples R China
[4] Beijing Univ Chinese Med, Sch Life Sci, Beijing 100029, Peoples R China
[5] Beijing Univ Chinese Med, Modern Res Ctr Tradit Chinese Med, Beijing, Peoples R China
[6] Guangzhou Univ Chinese Med, Guangzhou 510006, Peoples R China
基金
中国国家自然科学基金;
关键词
Myocardial I/R injury; Aggrephagy; Autolysosme; ERK1/2-Nrf2; LAMP2; Neocryptotanshinone; OXIDATIVE STRESS; DOWN-REGULATION; NRF2; ACTIVITY; CONTRIBUTES; PHOSPHORYLATION; ACTIVATION; CLEARANCE; AUTOPHAGY;
D O I
10.1016/j.phymed.2022.154625
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: Aggrephagy is a critical compensatory mechanism for the elimination of misfolded proteins resulting from stress and depends on the autolysosome degradation of protein aggregates. However, there have been few mechanism research related to aggrephagy in myocardial ischemia/reperfusion (I/R) injury. Neocryptotanshinone (NCTS) is a fat-soluble active compound extracted from Salvia miltiorrhiza, and may be cardioprotective against I/R. However, the efficacy and specific mechanism of NCTS on I/R have not been studied. Purpose: The current study aimed to investigate the molecular mechanism of NCTS involved in the therapeutic effect on I/R, with a special emphasis on the up-regulation of the ERK1/2-Nrf2-LAMP2 pathway to increase autolysosomal degradation during aggrephagy. Methods: A rat model of myocardial I/R injury was constructed by left anterior descending (LAD) ligationreperfusion. To verify cardiac protection, autolysosome clearance of protein aggregates, and their intracellular biological mechanism, an oxygen-glucose deprivation/recovery (OGD/R)-induced H9c2 cardiomyocyte model was created. Results: NCTS was found to have a significant cardioprotective effect in I/R rats as evidenced by remarkably improved pathological anatomy, decreased myocardial damage indicators, and substantially enhanced cardiac performance. Mechanistically, NCTS might boost the levels of LAMP2 mRNA and protein, total and Ser40 phosphorylated Nrf2, and (Thr202/Tyr204)p-ERK1/2 protein. Simultaneously, the cytoplasmic Nrf2 level was reduced after NCTS administration, which was contrary to the total Nrf2 content. However, these beneficial changes were reversed by the co-administration with ERK1/2 inhibitor, PD98059. NCTS therapy up-regulated Rab7 protein content, Cathepsin B activity, and lysosomal acidity, while down-regulating autophagosome numbers, Ubiquitin (Ub), and autophagosome marker protein accumulations through the above signaling pathway. This might indicate that NCTS enhanced lysosomal fusion and hydrolytic capacity. It was also found that NCTS intervention limited oxidative stress and cellular apoptosis both in vivo and in vitro. Conclusions: We reported for the first time that NCTS promoted the autolysosome removal of protein aggregation both in vivo and in vitro, to exert the therapeutic advantages of myocardial I/R injury. This was reliant on the upregulation of the ERK1/2-Nrf2-LAMP2 signaling pathway.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 Phosphorylation
    Bourke, Lauren
    McCormick, James
    Taylor, Valerie
    Pericleous, Charis
    Blanchet, Benoit
    Costedoat-Chalumeau, Nathalie
    Stuckey, Daniel
    Lythgoe, Mark F.
    Stephanou, Anastasis
    Ioannou, Yiannis
    PLOS ONE, 2015, 10 (12):
  • [32] Salvianolate Reduces Murine Myocardial Ischemia and Reperfusion Injury via ERK1/2 Signaling Pathways in vivo
    QI Jianyong
    YU Juan
    HUANG Donghui
    GUO Liheng
    WANG Lei
    HUANG Xin
    HUANG Haiding
    ZHOU Miao
    ZHANG Minzhou
    Jiashin Wu
    Chinese Journal of Integrative Medicine, 2017, 23 (01) : 40 - 47
  • [33] Salvianolate Reduces Murine Myocardial Ischemia and Reperfusion Injury via ERK1/2 Signaling Pathways in vivo
    Qi Jian-yong
    Yu Juan
    Huang Dong-hui
    Guo Li-heng
    Wang Lei
    Huang Xin
    Huang Hai-ding
    Zhou Miao
    Zhang Min-zhou
    Wu, Jiashin
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2017, 23 (01) : 40 - 47
  • [34] Salvianolate Reduces Murine Myocardial Ischemia and Reperfusion Injury via ERK1/2 Signaling Pathways in vivo
    QI Jian-yong
    YU Juan
    HUANG Dong-hui
    GUO Li-heng
    WANG Lei
    HUANG Xin
    HUANG Hai-ding
    ZHOU Miao
    ZHANG Min-zhou
    Jiashin Wu
    Chinese Journal of Integrative Medicine , 2017, (01) : 40 - 47
  • [35] Salvianolate reduces murine myocardial ischemia and reperfusion injury via ERK1/2 signaling pathways in vivo
    Jian-yong Qi
    Juan Yu
    Dong-hui Huang
    Li-heng Guo
    Lei Wang
    Xin Huang
    Hai-ding Huang
    Miao Zhou
    Min-zhou Zhang
    Jiashin Wu
    Chinese Journal of Integrative Medicine, 2017, 23 : 40 - 47
  • [36] EXENDIN-4 PROTECTS AGAINST RENAL ISCHEMIA-REPERFUSION INJURY THROUGH ACTIVATION OF NRF2 SIGNALING PATHWAY
    Yang, Chih-Chao
    Chuang, Feng-Rong
    Lee, Chih-Hsiung
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 400 - 400
  • [37] Sevoflurane protects the liver from ischemia-reperfusion injury by regulating Nrf2/HO-1 pathway
    Ma, Hongyan
    Yang, Baoyi
    Yu, Lu
    Gao, Yang
    Ye, Xiangmei
    Liu, Ying
    Li, Zhengtian
    Li, Hulun
    Li, Enyou
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 898
  • [38] Pharmacological Protection against Ischemia-Reperfusion Injury by Regulating the Nrf2-Keap1-ARE Signaling Pathway
    Ucar, Bercis Imge
    Ucar, Gulberk
    Saha, Sarmistha
    Buttari, Brigitta
    Profumo, Elisabetta
    Saso, Luciano
    ANTIOXIDANTS, 2021, 10 (06)
  • [39] Rapamycin protects against myocardial ischemia-reperfusion injury through JAK2-STAT3 signaling pathway
    Das, Anindita
    Salloum, Fadi N.
    Durrant, David
    Ockaili, Ramzi
    Kukreja, Rakesh C.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2012, 53 (06) : 858 - 869
  • [40] Xa inhibitor edoxaban ameliorates hepatic ischemia-reperfusion injury via PAR-2-ERK 1/2 pathway
    Maeda, Koki
    Kuriyama, Naohisa
    Noguchi, Daisuke
    Ito, Takahiro
    Gyoten, Kazuyuki
    Hayasaki, Aoi
    Fujii, Takehiro
    Iizawa, Yusuke
    Murata, Yasuhiro
    Tanemura, Akihiro
    Kishiwada, Masashi
    Mizuno, Shugo
    PLOS ONE, 2024, 19 (05):